In the last trading session, 0.86 million shares of the Lyra Therapeutics Inc (NASDAQ:LYRA) were traded, and its beta was 0.04. Most recently the company’s share price was $0.10, and it changed around -$0.01 or -4.16% from the last close, which brings the market valuation of the company to $6.84M. LYRA currently trades at a discount to its 52-week high of $4.71, offering almost -4610.0% off that amount. The share price’s 52-week low was $0.08, which indicates that the current value has risen by an impressive 20.0% since then.
Lyra Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 4 recommended LYRA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Lyra Therapeutics Inc (NASDAQ:LYRA) trade information
Instantly LYRA has showed a red trend with a performance of -4.16% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.1246 on recent trading dayincreased the stock’s daily price by 19.74%. The company’s shares are currently down -49.71% year-to-date, but still up 4.32% over the last five days. On the other hand, Lyra Therapeutics Inc (NASDAQ:LYRA) is -6.57% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $0.5, which translates to bulls needing to increase their stock price by 80.0% from its current value. Analyst projections state that LYRA is forecast to be at a low of $0.5 and a high of $0.5.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.22%. Lyra Therapeutics Inc earnings are expected to increase by 42.42% in 2025, but the outlook is positive 21.95% per year for the next five years.
LYRA Dividends
Lyra Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
CITADEL ADVISORS LLC, with 7.2912% or 4.77 million shares worth $1.32 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 2.37 shares worth $0.25 million, making up 3.59% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 992.54 shares worth around $0.1 million, which represents about 1.51% of the total shares outstanding.
